FSD Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	19	36	30	41	20	-	-
Market Cap Growth	-	20.48%	-27.10%	108.43%	-	-	-
Enterprise Value	12	28	18	14	6	-3	-12
PE Ratio	-2.69	-2.69	-1.74	-1.49	-0.79	-	-
PB Ratio	2.01	3.64	1.35	0.98	0.69	-	-
P/FCF Ratio	-4.45	-4.45	-1.43	-2.48	-1.32	-	-
P/OCF Ratio	-4.45	-4.45	-1.45	-2.54	-1.32	-	-
EV/EBITDA Ratio	-2.45	-2.45	-1.30	-0.57	-0.30	0.12	0.70
EV/EBIT Ratio	-2.11	-2.11	-1.05	-0.51	-0.26	0.11	0.69
EV/FCF Ratio	-3.49	-3.49	-0.86	-0.84	-0.43	0.31	0.70
Debt / Equity Ratio	0.03	0.03	0.02	0.01	0.01	0.04	0.00
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	-0.02	-0.02	-0.04	-0.01
Debt / FCF Ratio	-0.03	-0.03	-0.02	-0.03	-0.03	-0.11	-0.01
Quick Ratio	2.39	2.39	2.22	4.13	3.17	1.10	12.30
Current Ratio	2.43	2.43	2.28	4.29	3.27	1.25	12.55
Interest Coverage	-59872.51	-59872.51	-482.53	-507.41	-133.98	-250.93	-
Return on Equity (ROE)	-111.10%	-111.10%	-60.50%	-58.50%	-76.00%	-104.80%	-89.40%
Return on Assets (ROA)	-82.00%	-82.00%	-50.00%	-51.10%	-63.60%	-94.20%	-84.80%
Return on Capital (ROIC)	-175.23%	-175.23%	-88.32%	-61.70%	-83.36%	-59.38%	-85.19%
Earnings Yield	-69.38%	-37.18%	-57.34%	-66.88%	-126.12%	-	-
FCF Yield	-40.79%	-22.49%	-69.71%	-40.27%	-75.87%	-	-
Buyback Yield / Dilution	-2.21%	-2.21%	-10.84%	-190.15%	-70.69%	-19.49%	-169.63%
Total Shareholder Return	-2.21%	-2.21%	-10.84%	-190.15%	-70.69%	-19.49%	-169.63%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).